Please enable JS

About Us

MANAGEMENT TEAM

CRISPR Therapeutics is led by a seasoned management team focused on translating CRISPR/Cas9 technology into transformative gene-based medicines for patients with serious diseases. We are working in parallel with our world-class group of scientific founders and advisors, who have extensive experience in gene editing, stem cell biology, advanced drug delivery technologies, RNAi and gene silencing.
 

DR. RODGER NOVAK
Chief Executive Officer and Founder
DR. SAMARTH KULKARNI
President and Chief Business Officer
DR. SVEN ANTE (BILL) LUNDBERG
Chief Scientific Officer
MARC BECKER
Chief Financial Officer
DR. TYLER DYLAN-HYDE
Chief Legal Officer
JIM KASINGER
General Counsel and Secretary to the Board of Directors
DR. KALA SUBRAMANIAN
Senior Vice President, Strategic Development and Operations
DR. CHAD COWAN
Scientific Founder and Head of Research
MEGAN WHERRY MENNER
Senior Vice President, Human Resources
DR. JON TERRETT
Head of Immuno-Oncology Research and Translation